ZMYND19
gene geneOn this page
Also known as MIZIP
Summary
ZMYND19 (zinc finger MYND-type containing 19, HGNC:21146) is a protein-coding gene on chromosome 9q34.3, encoding Zinc finger MYND domain-containing protein 19 (Q96E35). May be involved as a regulatory molecule in GPR24/MCH-R1 signaling.
ZMYND19 is a MYND zinc finger domain-containing protein that binds to the C terminus of melanin-concentrating hormone receptor-1 (MCHR1; MIM 601751) (Bachner et al., 2002 [PubMed 12208518]), and to the N termini of alpha-tubulin (TUBA1; MIM 191110), and beta-tubulin (TUBB; MIM 191130) (Francke et al., 2005 [PubMed 16039987]).
Source: NCBI Gene 116225 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 35 total — 1 likely-pathogenic
- MANE Select transcript:
NM_138462
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21146 |
| Approved symbol | ZMYND19 |
| Name | zinc finger MYND-type containing 19 |
| Location | 9q34.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MIZIP |
| Ensembl gene | ENSG00000165724 |
| Ensembl biotype | protein_coding |
| OMIM | 611424 |
| Entrez | 116225 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000298585, ENST00000471957, ENST00000923514, ENST00000942290, ENST00000942291
RefSeq mRNA: 1 — MANE Select: NM_138462
NM_138462
CCDS: CCDS7048
Canonical transcript exons
ENST00000298585 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001095856 | 137582081 | 137582686 |
| ENSE00001120759 | 137582983 | 137583163 |
| ENSE00001120767 | 137586967 | 137587107 |
| ENSE00001120774 | 137587717 | 137587823 |
| ENSE00001120778 | 137588659 | 137588718 |
| ENSE00001300681 | 137590213 | 137590512 |
Expression profiles
Bgee: expression breadth ubiquitous, 236 present calls, max score 93.56.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 19.3383 / max 168.8527, expressed in 1774 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 103384 | 19.3383 | 1774 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 93.56 | gold quality |
| right testis | UBERON:0004534 | 93.52 | gold quality |
| testis | UBERON:0000473 | 91.66 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 91.10 | gold quality |
| body of stomach | UBERON:0001161 | 89.20 | gold quality |
| cortical plate | UBERON:0005343 | 89.19 | gold quality |
| skin of leg | UBERON:0001511 | 89.07 | gold quality |
| skin of abdomen | UBERON:0001416 | 88.71 | gold quality |
| esophagus mucosa | UBERON:0002469 | 88.35 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 87.73 | gold quality |
| prefrontal cortex | UBERON:0000451 | 87.42 | gold quality |
| apex of heart | UBERON:0002098 | 87.31 | gold quality |
| metanephros cortex | UBERON:0010533 | 87.30 | gold quality |
| right frontal lobe | UBERON:0002810 | 87.10 | gold quality |
| zone of skin | UBERON:0000014 | 87.01 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 86.92 | gold quality |
| embryo | UBERON:0000922 | 86.68 | gold quality |
| ganglionic eminence | UBERON:0004023 | 86.68 | gold quality |
| adenohypophysis | UBERON:0002196 | 86.67 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 86.64 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 86.59 | gold quality |
| granulocyte | CL:0000094 | 86.58 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 86.55 | gold quality |
| stomach | UBERON:0000945 | 86.48 | gold quality |
| cerebellar cortex | UBERON:0002129 | 86.41 | gold quality |
| putamen | UBERON:0001874 | 86.35 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 86.12 | gold quality |
| right lobe of liver | UBERON:0001114 | 86.04 | gold quality |
| caudate nucleus | UBERON:0001873 | 85.92 | gold quality |
| minor salivary gland | UBERON:0001830 | 85.90 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-137537 | yes | 1452.03 |
| E-ANND-3 | yes | 3.69 |
| E-CURD-10 | no | 51.06 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
43 targeting ZMYND19, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-96-5P | 99.95 | 72.80 | 2140 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-12133 | 99.92 | 71.82 | 2006 |
| HSA-MIR-1271-5P | 99.91 | 71.99 | 1972 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-MIR-548AZ-3P | 99.82 | 70.56 | 3549 |
| HSA-MIR-548BC | 99.82 | 70.61 | 3524 |
| HSA-MIR-548E-3P | 99.82 | 70.59 | 3514 |
| HSA-MIR-548F-3P | 99.82 | 70.59 | 3540 |
| HSA-MIR-548A-3P | 99.76 | 70.58 | 3524 |
| HSA-MIR-3120-3P | 99.54 | 70.28 | 2669 |
| HSA-MIR-548G-3P | 99.48 | 68.67 | 2159 |
| HSA-MIR-3692-5P | 99.29 | 67.04 | 1421 |
| HSA-MIR-4477B | 99.23 | 70.49 | 1733 |
Literature-anchored findings (GeneRIF, showing 2)
- was identified from human brain and interacts with the C-terminus of melanin-concentrating hormone receptor 1 (PMID:12208518)
- Our results suggest that MIZIP might play an important role in mammalian cells by associating with tubulin and thus might provide a link between MCHR1 and tubulin functions. (PMID:16039987)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zmynd19 | ENSDARG00000100773 |
| mus_musculus | Zmynd19 | ENSMUSG00000026974 |
| rattus_norvegicus | Zmynd19 | ENSRNOG00000007752 |
| drosophila_melanogaster | Zmynd10 | FBGN0266709 |
Paralogs (2): ZMYND10 (ENSG00000004838), MSS51 (ENSG00000166343)
Protein
Protein identifiers
Zinc finger MYND domain-containing protein 19 — Q96E35 (reviewed: Q96E35)
Alternative names: Melanin-concentrating hormone receptor 1-interacting zinc finger protein
All UniProt accessions (1): Q96E35
UniProt curated annotations — full annotation on UniProt →
Function. May be involved as a regulatory molecule in GPR24/MCH-R1 signaling.
Subunit / interactions. Interacts with GPR24/MCH-R1.
Subcellular location. Cytoplasm. Cell membrane.
Tissue specificity. Expressed in brain, testis, placenta, heart, liver, skeletal muscle, kidney and stomach.
RefSeq proteins (1): NP_612471* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002893 | Znf_MYND | Domain |
| IPR003615 | HNH_nuc | Domain |
| IPR032978 | ZMYND19 | Family |
| IPR044925 | His-Me_finger_sf | Homologous_superfamily |
Pfam: PF01753, PF13392
UniProt features (6 total): binding site 4, chain 1, zinc finger region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96E35-F1 | 83.80 | 0.52 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (4): 187; 190; 208; 212
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 87 (showing top):
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, FISCHER_G1_S_CELL_CYCLE, ATGTTAA_MIR302C, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, WEI_MYCN_TARGETS_WITH_E_BOX, LIAO_METASTASIS, FISCHER_DREAM_TARGETS, DOUGLAS_BMI1_TARGETS_UP, GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN, ATGTACA_MIR493, GOCC_SYNAPSE, MARSON_BOUND_BY_E2F4_UNSTIMULATED, SANSOM_APC_MYC_TARGETS, SANSOM_APC_TARGETS_REQUIRE_MYC, KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
GO Biological Process (0):
GO Molecular Function (3): zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (4): cytoplasm (GO:0005737), plasma membrane (GO:0005886), membrane (GO:0016020), synapse (GO:0045202)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular anatomical structure | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cell junction | 1 |
Protein interactions and networks
STRING
752 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZMYND19 | FAM170A | A1A519 | 826 |
| ZMYND19 | DEAF1 | O75398 | 810 |
| ZMYND19 | MCHR1 | Q99705 | 779 |
| ZMYND19 | TUBA4A | P05215 | 750 |
| ZMYND19 | TUBB2A | Q13885 | 639 |
| ZMYND19 | TUBB | P05218 | 634 |
| ZMYND19 | ARMC8 | Q8IUR7 | 607 |
| ZMYND19 | HTRA2 | O43464 | 576 |
| ZMYND19 | RUNX1T1 | Q06455 | 547 |
| ZMYND19 | MAEA | Q7L5Y9 | 540 |
| ZMYND19 | RMND5A | Q9H871 | 509 |
| ZMYND19 | PLEKHJ1 | Q9NW61 | 445 |
| ZMYND19 | TTC14 | Q96N46 | 439 |
| ZMYND19 | TMEM168 | Q9H0V1 | 431 |
| ZMYND19 | CCDC28A | Q8IWP9 | 430 |
IntAct
289 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HACL1 | ZMYND19 | psi-mi:“MI:0915”(physical association) | 0.830 |
| ZMYND19 | HACL1 | psi-mi:“MI:0915”(physical association) | 0.830 |
| ZMYND19 | NAB2 | psi-mi:“MI:0915”(physical association) | 0.780 |
| KCTD13 | ZMYND19 | psi-mi:“MI:0915”(physical association) | 0.780 |
| ZMYND19 | KCTD13 | psi-mi:“MI:0915”(physical association) | 0.780 |
| NAB2 | ZMYND19 | psi-mi:“MI:0915”(physical association) | 0.780 |
| SELENOV | ZMYND19 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZMYND19 | SAXO1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TOX4 | ZMYND19 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZMYND19 | ENOX1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| PNMA5 | ZMYND19 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZMYND19 | SELENOV | psi-mi:“MI:0915”(physical association) | 0.720 |
| SAXO1 | ZMYND19 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZMYND19 | PNMA5 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ENOX1 | ZMYND19 | psi-mi:“MI:0915”(physical association) | 0.720 |
BioGRID (170): ZMYND19 (Two-hybrid), ZMYND19 (Two-hybrid), ZMYND19 (Two-hybrid), ZMYND19 (Two-hybrid), ZMYND19 (Two-hybrid), ZMYND19 (Two-hybrid), ZMYND19 (Two-hybrid), ZMYND19 (Two-hybrid), FAM154A (Two-hybrid), KCTD13 (Two-hybrid), SELV (Two-hybrid), INCA1 (Two-hybrid), CCDC183 (Affinity Capture-MS), ZMYND19 (Affinity Capture-MS), ZMYND19 (Affinity Capture-MS)
ESM2 similar proteins: A2VDK9, A3KN28, A5PK00, A8C8W3, A9JRA0, O04300, O22666, O43513, P03455, P0A4M1, P0A4M2, P0C0A2, P11497, P26140, P29010, P33790, P61008, P61009, P76512, Q05B58, Q108U3, Q13085, Q28559, Q28GR4, Q2F7Z4, Q2QL86, Q2TBU2, Q3SZU5, Q3T123, Q3ZAQ7, Q5RDV3, Q5RF53, Q5SWU9, Q6ZWQ7, Q78T54, Q86VN1, Q8H8T0, Q8RU27, Q8X5L8, Q91XD6
Diamond homologs: A9CPT4, C3RZA1, D3ZKV9, E1C5V0, F1QN74, F1RET2, O74467, P97443, Q0P585, Q12529, Q3TYX3, Q4VC12, Q5BJI7, Q5F3V0, Q5R5X9, Q5RGL7, Q5UNT8, Q5ZIZ2, Q6C9E7, Q6GMV2, Q6GN68, Q6GPQ4, Q7M6Z3, Q7TSV3, Q7ZXV5, Q8BTK5, Q8IYR2, Q8NB12, Q8R5A0, Q91YE3, Q96E35, Q9BXT4, Q9CQG3, Q9CWR2, Q9D5Z5, Q9GZT9, Q9H7B4, Q9N3Q8, Q9NRG4, A3M0J3
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 90 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Aerobic respiration and respiratory electron transport | 6 | 10.0× | 5e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
35 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 24 |
| Likely benign | 0 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2576633 | GRCh37/hg19 9q34.3(chr9:140233379-140756825)x3 | Likely pathogenic |
SpliceAI
1025 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:137582978:CCCA:C | donor_loss | 1.0000 |
| 9:137582979:CCA:C | donor_loss | 1.0000 |
| 9:137582980:CA:C | donor_loss | 1.0000 |
| 9:137582981:A:AT | donor_loss | 1.0000 |
| 9:137582982:C:CG | donor_loss | 1.0000 |
| 9:137582982:CCTG:C | donor_gain | 1.0000 |
| 9:137583162:CC:C | acceptor_gain | 1.0000 |
| 9:137583163:CCT:C | acceptor_gain | 1.0000 |
| 9:137583164:C:T | acceptor_gain | 1.0000 |
| 9:137583165:T:C | acceptor_gain | 1.0000 |
| 9:137586966:CCT:C | donor_gain | 1.0000 |
| 9:137587752:T:A | donor_gain | 1.0000 |
| 9:137587819:CGGGC:C | acceptor_gain | 1.0000 |
| 9:137587822:GCC:G | acceptor_loss | 1.0000 |
| 9:137587824:C:CC | acceptor_gain | 1.0000 |
| 9:137587825:T:C | acceptor_loss | 1.0000 |
| 9:137588656:TACCT:T | donor_loss | 1.0000 |
| 9:137588657:A:AC | donor_gain | 1.0000 |
| 9:137588657:AC:A | donor_gain | 1.0000 |
| 9:137588657:ACC:A | donor_loss | 1.0000 |
| 9:137588658:C:CA | donor_gain | 1.0000 |
| 9:137588658:CC:C | donor_gain | 1.0000 |
| 9:137588658:CCT:C | donor_gain | 1.0000 |
| 9:137583023:T:C | donor_gain | 0.9900 |
| 9:137583044:T:TA | donor_gain | 0.9900 |
| 9:137583160:CTCC:C | acceptor_gain | 0.9900 |
| 9:137583161:TCCCT:T | acceptor_loss | 0.9900 |
| 9:137583162:CCCT:C | acceptor_gain | 0.9900 |
| 9:137583164:C:CA | acceptor_loss | 0.9900 |
| 9:137583164:C:CC | acceptor_gain | 0.9900 |
AlphaMissense
1483 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:137582593:A:G | C212R | 1.000 |
| 9:137582612:C:A | W205C | 1.000 |
| 9:137582612:C:G | W205C | 1.000 |
| 9:137582614:A:G | W205R | 1.000 |
| 9:137582614:A:T | W205R | 1.000 |
| 9:137582628:C:G | C200S | 1.000 |
| 9:137582629:A:G | C200R | 1.000 |
| 9:137582629:A:T | C200S | 1.000 |
| 9:137582641:A:G | C196R | 1.000 |
| 9:137582644:A:C | Y195D | 1.000 |
| 9:137582644:A:G | Y195H | 1.000 |
| 9:137582657:G:C | C190W | 1.000 |
| 9:137582658:C:A | C190F | 1.000 |
| 9:137582658:C:G | C190S | 1.000 |
| 9:137582658:C:T | C190Y | 1.000 |
| 9:137582659:A:G | C190R | 1.000 |
| 9:137582659:A:T | C190S | 1.000 |
| 9:137582666:A:C | C187W | 1.000 |
| 9:137582667:C:G | C187S | 1.000 |
| 9:137582667:C:T | C187Y | 1.000 |
| 9:137582668:A:G | C187R | 1.000 |
| 9:137582668:A:T | C187S | 1.000 |
| 9:137582675:G:C | F184L | 1.000 |
| 9:137582675:G:T | F184L | 1.000 |
| 9:137582676:A:G | F184S | 1.000 |
| 9:137582677:A:G | F184L | 1.000 |
| 9:137583003:A:G | C174R | 1.000 |
| 9:137583016:G:C | C169W | 1.000 |
| 9:137583017:C:G | C169S | 1.000 |
| 9:137583017:C:T | C169Y | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000365012 (9:137591083 C>G,T), RS1000438762 (9:137591364 C>G,T), RS1000458971 (9:137584274 T>C,G), RS1000617867 (9:137588472 G>C,T), RS1000697740 (9:137590491 C>A,T), RS1001167594 (9:137591694 G>A,C), RS1001184242 (9:137586936 G>A), RS1001354888 (9:137586403 G>C), RS1001398121 (9:137581990 C>T), RS1001426463 (9:137587216 G>A), RS1001651184 (9:137590856 C>T), RS1001767621 (9:137581727 G>A,C), RS1001870632 (9:137591928 G>A,C), RS1001900751 (9:137582909 G>A,C), RS1001928888 (9:137587540 G>A)
Disease associations
OMIM: gene MIM:611424 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007267_194 | Systolic blood pressure | 1.000000e-08 |
| GCST007994_19 | Asthma (age of onset) | 3.000000e-08 |
| GCST007995_55 | Asthma (childhood onset) | 4.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006335 | systolic blood pressure |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium Chloride | decreases expression, increases expression | 3 |
| Acetaminophen | increases expression, decreases expression | 2 |
| Tretinoin | decreases expression, increases expression | 2 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 2 |
| sodium arsenite | decreases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | decreases expression | 1 |
| 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | decreases expression, increases response to substance | 1 |
| NSC 689534 | affects binding, decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Cadmium | decreases expression | 1 |
| Copper | affects binding, decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| tert-Butylhydroperoxide | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.